Met
null The MET family of receptor tyrosine kinases contains MET, the receptor for hepatocyte growth factor (HGF, scatter factor), and RON (MST1R), the receptor for macrophage-stimulating protein. Both receptors have a characteristic extracellular sema domain, found also in plexins and semaphorins, plus a PSI domain and four immunoglobulin-like repeats. Ligand-induced dimerization triggers kinase activation and a program of invasive growth involving scattering, proliferation, survival, angiogenesis and morphogenesis, essential for embryogenesis, liver regeneration and wound healing. MET is pathologically activated by exon 14 skipping, amplification and activating mutations in lung, gastric, liver and kidney cancers, and by HGF overexpression. MET inhibitors such as cabozantinib, capmatinib and tepotinib are now approved anticancer agents.
-
Met 組換えタンパク質 (36)
HGFR Protein, Human (Active, sf9, His-GST)
0 Images
製品番号: HY-P72938
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
- 生物種:
- 由来:
HGFR Protein, Human (Active, ΔD963-E1009, sf9, His-GST)
0 Images
製品番号: HY-P705789
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, D1228N, sf9, His-GST)
0 Images
製品番号: HY-P72938A
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
RON/MSPR Protein, Human (Active, sf9, GST)
0 Images
製品番号: HY-P705604
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MST1R; S13 Avian Erythroblastosis Oncogene Homolog; Prev. PTK8; C-Met-Related Tyrosine Kinase; Prev. RON; MSP Receptor; Prev. SEA; S13 Erythroblastosis (Avian) Oncogene Homolog; CDw136; S13 Erythroblastosis Oncogene Homolog; Macrophage-Stimulating Protein
- 生物種:
- 由来:
HGFR Protein, Human (Active, M1250I, sf9, His-GST)
0 Images
製品番号: HY-P705764
純度: ≥ 85%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, T1173I, sf9, His-GST)
0 Images
製品番号: HY-P705765
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, K1244R, sf9, His-GST)
0 Images
製品番号: HY-P705766
純度: ≥ 80%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, L1195V, sf9, His-GST)
0 Images
製品番号: HY-P705767
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, M1250T, sf9, His-GST)
0 Images
製品番号: HY-P705768
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, T992I, sf9, His-GST)
0 Images
製品番号: HY-P705769
純度: ≥ 85%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, V1092I, sf9, His-GST)
0 Images
製品番号: HY-P705770
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, Y1230A, sf9, His-GST)
0 Images
製品番号: HY-P705771
純度: ≥ 95%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, Y1230H, sf9, His-GST)
0 Images
製品番号: HY-P705772
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, F1200I, sf9, His-GST)
0 Images
製品番号: HY-P705773
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, L1195F, sf9, His-GST)
0 Images
製品番号: HY-P705774
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, R970C, sf9, His-GST)
0 Images
製品番号: HY-P705775
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, D1228A, sf9, His-GST)
0 Images
製品番号: HY-P705776
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, D1228G, sf9, His-GST)
0 Images
製品番号: HY-P705777
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, D1228H, sf9, His-GST)
0 Images
製品番号: HY-P705778
純度: ≥ 90%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
HGFR Protein, Human (Active, D1228V, sf9, His-GST)
0 Images
製品番号: HY-P705779
純度: ≥ 85%, as determined by reducing SDS-PAGE.
別名: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; Hepatocyte Growth Factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosine-Protein Kinase Met; Soluble MET Variant 5; Scatter Factor Receptor; Soluble MET Variant 6; Proto-Oncogene C-Met; Soluble MET Variant 7; HGF/SF Receptor; Soluble MET Variant 8; HGF Receptor; Soluble MET Variant 9; SF Receptor; Met Proto-Oncogene; Met Proto-Oncogene Variant I; MET Protein; Proto-Oncogenic Met Protein; AUTS9; Soluble MET Variant 10; C-Met; Soluble MET Variant 11; DA11; Soluble MET Variant 12
- 生物種:
- 由来:
- 1
- 2
Recombinant Protein Expression Service
- Codon Optimization
- Gene Synthesis
- Construction of Expression Vector
- Strain Screening
- Protein Expression
- Purification & QC
- Protein Delivery
- 1
- 2
Capetin (28-54), human
0 Images
- 分子式: Human
- 分子量: Sf9 insect cells
The EpCAM/TROP1 protein serves as an important homogeneous interacting molecule that promotes direct contact between intestinal epithelial cells (IEC) and intraepithelial lymphocytes (IEL) in the mucosal epithelium. This feature helps establish an immune barrier against mucosal infections. EpCAM/TROP1 Protein, Human (His-SUMO) is the recombinant human-derived EpCAM/TROP1 protein, expressed by E. coli , with N-6*His, N-SUMO labeled tag.
